Home > Insider Trading > Filing (0001209191-11-005084)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
786947	Acura Pharmaceuticals Inc	ACUR	Pharmaceutical Preparations (2834)	110853640

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1056695	A Peter Clemens	C/O Acura Pharmaceuticals, Inc. 616 N. North Court, Suite 120 Palatine IL 60067	Senior Vp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-01-25	9,375	$1.30	437,187	No	4	M	Direct
Common Stock	Acquisiton	2011-01-26	350	$2.98	2,605	No	4	P	Indirect	by son

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	P	Indirect	by son

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2011-01-25	9,375	$0.00	9,375	$1.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,125	2011-01-01	2014-03-09	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,522	Indirect	by daughter

Footnotes

Amount of securities include 352,500 Restricted Stock Units held by Reporting Person. Absent a change of control, shares of common stock will be distributed in exchange for Restricted Stock Units (after payment of $.01 par value per share) in three equal installments on January 1st of each of 2012, 2013 and 2014.
Option is exercsiable with respect to 9,375 shares commencing January 1, 2011. Remaining portion of option is exercisable (absent a change of control) in three equal installments commencing on January 1 of each of 2012, 2013 and 2014, and each installment must be exercised in year in which it first becomes exercisable.
Not Applicable